Company / R&D per Share
GE HealthCare R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.75
FY2025
5-year range
$1.80 / $8160000.00
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#28 of 108
Health Care
What the data says
At $2.75, GE HealthCare's r&d per share ranks #28 of 108 in the Health Care sector. Declined from $8160000.00 to $2.75 over the past 2 years.
Based on SEC 10-K filings.
2.75 in FY2025 with a 3-year CAGR of +6.8%.
Declined from $8160000.00 to $2.75 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#28 of 108 in Health CareTop 26% of 108This company $2.75 Sector average $2.07
▼
+32.9% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 4.7% year-over-year.
- Ranks #28 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- Strong return on equity: 22.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.75 | -4.7% |
| FY2024 | $2.89 | -100.0% |
| FY2023 | $8160000.00 | +361075923.4% |
| FY2022 | $2.26 | +25.7% |
| FY2021 | $1.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026